Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Bayir et al, 2009 USA | Infants and children with severe TBI (Glasgow Coma Scale (GCS) less than score <8. 13 patients randomized to hypothermia group and 15 patients randomized to normothermia group. | RCT | Antioxidant Reserve, CSF levels on Day 1-3 | Preservation of CSF antioxidant reserve by hypothermia (p 0.001) | small sample size, single center study. |
Glutathione levels, CSF levels on Day 1-3 | Glutathione levels were inversely associated with patient temperature at the time of sampling (p 0.002) | ||||
Lipid Peroxidation levels, CSF levels on Day 1-3 | F2-isoprostane levels were approximately threefold lower in patients randomized to hypothermia vs. normothermia, however this difference was not statistically significant. | ||||
Hutchison et al, 2008 Canada | In a multicenter, international trial, 225 children with severe traumatic brain injury were randomly assigned to either hypothermia therapy (32.5°C for 24 hours) initiated within 8 hours after injury or to normothermia (37.0°C). | RCT | Unfavorable outcomes (severe disability, persistent vegetative state, or death) at 6 months | At 6 months, 31% of the patients in the hypothermia group, as compared with 22% of the patients in the normothermia group, had an unfavorable outcome (relative risk, 1.41; 95% confidence interval [CI], 0.89 to 2.22; P = 0.14) | Mean time to the initiation of hypothermia was greater than 6 hours. |
Mortality | There were 23 deaths (21%) in the hypothermia group and 14 deaths (12%) in the normothermia group (relative risk, 1.40; 95% CI, 0.90 to 2.27; P = 0.06). | ||||
Hypotension | There was more hypotension (P = 0.047) and more vasoactive agents were administered (P<0.001) in the hypothermia group during the rewarming period than in the normothermia group. | ||||
Length of Stay (ICU, and total hospital stay) | No difference in lengths of stay in the intensive care unit or the total hospital time between the groups. | ||||
Biswas et al, Dec USA | Children up to 18 yrs of age, who presented with an admission GCS<8, admitted to the pediatric intensive care unit within 6 hrs of injury, and underwent placement of an intracranial pressure(ICP) monitor. A total of 21 patients were enrolled in the study, 11 in the normothermia group and 10 in the hypothermia group. | RCT | ICP | No significant difference between study groups with respect to change in ICP over time (p 0.73). No significant difference between study groups with respect to overall ICP level (p 0.77) | Small sample size, single center study. |
Arterial pH and Serum osmolarity | No significant change in arterial pH or serum osmolarity over study days (p >0.5) | ||||
Venous pH | No change in jugular venous pH for the hypothermia group (p 0.317) | ||||
Venous Lactate | Venous lactate decreased over study days for all patients (p <0.001) | ||||
WBC, hemoglobin concentration, hematocrit, platelet count, prothrombin time, partial thromboplastin time, and fibrinogen | No significant differences between study groups or significant changes over study days (p >0.09) | ||||
Adjuncts used to keep ICP levels controlled | No significant difference between the groups on any of the study days, nor within either group over time. A trend toward lower mean scores with narrower standard deviations was present in the hypothermia group. | ||||
Functional Outcome Assessment | No significant changes in Glasgow Outcome Score, Pediatric Cerebral Performance Category, or Pediatric Overall Performance Category from 3 to 12 months (P > 0.1) | ||||
Adelson et al. 2005 USA | 48 children less than 13 years of age admitted within 6 hours of injury were randomized after stratification by age to moderate hypothermia (HYPO) [32–33°C]treatment in conjunction with standardized head injury management versus normothermia (NORM) in a multicenter trial. An additional 27 patients were entered into a parallel single-institution trial of excluded patients because of late transfer or consent. | RCT | Mortality | No mortality difference between HYPO (2 of 23 patients [8%]) and NORM (4 of 25 patients [16%]) (P 0.44) | Small patient population. Single Center. |
Primary Complications (temperature deviation, infection, arrhythmia, and coagulopathy) | No differences between treatment groups with respect to coagulopathy, arrhythmia, or infection | ||||
Secondary Complications (anemia, aspiration, cardiac arrest, diabetes insipidus, extra-axial hematoma, hyperglycemia, hypokalemia, hypotension, hypoxemia, hydrocephalus, intraparenchymal hemorrhage, pneumothorax, and pulmonary edema) | Increased trend to arrhythmias in HYPO when compared with NORM. 7 patients had arrhythmias: 2 (8%) in the NORM group and 5 (22%) in the HYPO group | ||||
ICP | No statistical difference in mean ICP between the groups during the 5-day period (P 0.037) except within the first 24 hours, when the ICP was lower in the HYPO group(P 0.024). | ||||
Neurocognitive Functional Outcome | No statistically significant differences between treatment groups | ||||
Li et al, 2009 China | 22 children with GCS < 8 admitted to the Children's Hospital of Fudan University. 12 Children randomly assigned to moderate hypothermia group (intracranial temperature of 34.5 maintained for 72 hours). 10 children assigned to normothermia group (intracranial temperature of 38.0). | RCT | ICP | ICP was lower in the hypothermia group at all points measured during this study (p<0.01) | Small patient population. Single Center. Outcomes do not measure long term neurologic function. |
CSF levels of Neuron Specific Enolase (NSE), brain specific creatine kinase (CK-BB), and S-100 | All levels lower in hypothermia group at 24hr, 48hr, and 72 hr (p<0.01) |